Your session is about to expire
← Back to Search
Sleep Interventions for Alcohol Use (MoRA Trial)
N/A
Recruiting
Led By Melynda D Casement, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to understand how stress, sleep, and alcohol interact in young adults, to inform preventative interventions for alcohol use disorders. #health #prevention
Who is the study for?
This trial is for English-speaking young adults aged 18-24 who engage in high-risk drinking as defined by NIAAA and have specific sleep patterns. They must have experienced moderate stress in their lifetime but can't participate if they've recently traveled across time zones, changed medications, or are at risk of suicide.
What is being tested?
The study investigates how life stress and sleep habits (both duration and timing) relate to alcohol use in young adults. It aims to understand these connections better to eventually help prevent alcohol use disorders.
What are the potential side effects?
Since the interventions involve changes in sleep patterns rather than medication, typical drug side effects aren't expected. However, altering one's sleep schedule could potentially lead to temporary fatigue or mood changes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Alcohol use
Reward-related brain function
Stress-related brain function
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep extension and advance "Lark Routine"Experimental Treatment1 Intervention
Participants go to bed 90 minutes earlier than their typical average bedtime to extend sleep duration and advance sleep timing
Group II: Regular sleep duration and timing "Owl Routine"Active Control1 Intervention
Participants go to bed at their typical average bedtime
Find a Location
Who is running the clinical trial?
University of PittsburghOTHER
1,787 Previous Clinical Trials
16,359,263 Total Patients Enrolled
16 Trials studying Alcoholism
4,633 Patients Enrolled for Alcoholism
University of OregonLead Sponsor
85 Previous Clinical Trials
44,148 Total Patients Enrolled
2 Trials studying Alcoholism
856 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
835 Previous Clinical Trials
1,082,784 Total Patients Enrolled
456 Trials studying Alcoholism
823,696 Patients Enrolled for Alcoholism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have serious heart issues, neurological disorders, or a history of significant head injuries.I am currently experiencing symptoms of an airborne illness.I have a sleep disorder that is not insomnia, delayed sleep phase disorder, or hypersomnia.I have eye disease, epilepsy, or take medication that increases light sensitivity.I am not using melatonin or am willing to stop during the study.I started or will start a new medication within 2 months of this study.I am not currently attending high school.I am between 18 and 24 years old.I haven't changed my medication dose recently.I have traveled across two or more time zones in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: Regular sleep duration and timing "Owl Routine"
- Group 2: Sleep extension and advance "Lark Routine"
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger